Description

Book Synopsis

Following the success of the first edition, this book is designed to provide practical and timely information for toxicologic pathologists working in pharmaceutical drug discovery and development. The majority of the book (Organ Systems) will provide detailed descriptions of histopathological lesions observed in drug development. In addition, it will provide information to assist the pathologist in making determinations of the origin of lesions as well as its relevance to human risk.

Toxicologic Pathology: Nonclinical Safety Assessment, Second Edition includes 2 new concept chapters. The first of the new chapters address approaches for the evaluation of unique therapeutic modalities such as cell therapies, gene therapies, and gene expression knockdown therapies. While these still represent new developing therapeutic approaches, there has been significant experience with the therapeutic modalities in the last 5 years. The second new chapter ad

Trade Review

"...the editors have achieved a truly remarkable feat in pulling together over 70 of the top toxicologic pathologists, the majority of whom are still practicing in their respective fields.

"This book has much to recommend it to both the experienced toxicologist and toxicologic pathologist and to beginners in the field of drug development. The accumulated knowledge of the contributing authors, much of which has never been published before, makes this a classic that should be in use for many years to come."

-John R. Foster, ToxPath Sciences Ltd, Congleton, Cheshire, UK
Toxicologic Pathology 2019, Vol. 47(7) 902

Full review available at: https://journals.sagepub.com/doi/pdf/10.1177/0192623319861939


"...the editors have achieved a truly remarkable feat in pulling together over 70 of the top toxicologic pathologists, the majority of whom are still practicing in their respective fields.

"This book has much to recommend it to both the experienced toxicologist and toxicologic pathologist and to beginners in the field of drug development. The accumulated knowledge of the contributing authors, much of which has never been published before, makes this a classic that should be in use for many years to come."

-John R. Foster, ToxPath Sciences Ltd, Congleton, Cheshire, UK
Toxicologic Pathology 2019, Vol. 47(7) 902

Full review available at: https://journals.sagepub.com/doi/pdf/10.1177/0192623319861939



Table of Contents

Preface

Acknowledgments

Editors

Contributors

Section I Concepts in Drug Development

Chapter 1 Overview of Drug Development

James A. Popp and Jeffery A. Engelhardt

Chapter 2 Nonclinical Safety Evaluation of Drugs

Thomas M. Monticello and Jeanine L. Bussiere

Chapter 3 Nonclinical Safety Evaluation of Advanced Therapies

Timothy K. MacLachlan, Kendall S. Frazier, and Mercedes Serabian

Chapter 4 Nonclinical Safety Evaluation of Medical Devices

Kathleen A. Funk, Victoria A. Hampshire, and JoAnn C. L. Schuh

Chapter 5 Pathology and the Pathologist in Pharmaceutical Research and Development

Page R. Bouchard, Christopher J. Clarke, and Dominique Brees

Chapter 6 Routine and Special Techniques in Toxicologic Pathology

Daniel J. Patrick, Matthew L. Renninger, and Peter C. Mann

Chapter 7 Principles of Clinical Pathology

Niraj K. Tripathi and Jacqueline M. Tarrant

Chapter 8 Toxicokinetics and Drug Disposition

David D. Christ

Chapter 9 Toxicogenomics in Toxicologic Pathology

Arun R. Pandiri, David E. Malarkey, and Mark J. Hoenerhoff

Chapter 10 Spontaneous Lesions in Control Animals Used in Toxicity Studies

Robert C. Johnson, Robert H. Spaet, Gitte Jeppesen, Ursula Junker, and Robert Stull

Section II Organ Systems

Chapter 11 Gastrointestinal Tract

Judit E. Markovits, Graham R. Betton, Donald N. McMartin, and Theresa Boulineau

Chapter 12 Liver, Gallbladder, and Exocrine Pancreas

Russell C. Cattley, James A. Popp, and Steven L. Vonderfecht

Chapter 13 Respiratory System

Tom P. McKevitt and David J. Lewis

Chapter 14 Urinary System

Kendall S. Frazier and John Curtis Seely

Chapter 15 Hematopoietic System

Kristin Henson, Tanasa Osborne, and Gregory S. Travlos

Chapter 16 The Lymphoid System

Patrick J. Haley

Chapter 17 Bone, Muscle, and Tooth

John L. Vahle, Joel R. Leininger, Philip H. Long, D. Greg Hall, and Heinrich Ernst

Chapter 18 The Cardiovascular System

Calvert Louden, David Brott, Chidozie J. Amuzie, Bindu Bennet, and Ronnie Chamanza

Chapter 19 Endocrine Glands

Richard A. Peterson, Sundeep Chandra, and Mark J. Hoenerhoff

Chapter 20 Reproductive System and Mammary Gland

Justin D. Vidal, Charles E. Wood, Karyn Colman, Katharine M. Whitney, and Dianne M. Creasy

Chapter 21 Skin

Zbigniew W. Wojcinski, Lydia Andrews-Jones, Daher Ibrahim Aibo, Rie Kikkawa, and Robert Dunstan

Chapter 22 Nervous System

Mark T. Butt, Alys Bradley, and Robert Sills

Chapter 23 Special Senses: Eye and Ear

Kenneth A. Schafer, Oliver C. Turner, and Richard A. Altschuler

Index

Toxicologic Pathology

    Product form

    £266.00

    Includes FREE delivery

    RRP £280.00 – you save £14.00 (5%)

    Order before 4pm today for delivery by Fri 12 Jun 2026.

    A Hardback by James A. Popp, Jerry F. Hardisty

    Out of stock


      View other formats and editions of Toxicologic Pathology by

      Publisher: Taylor & Francis Inc
      Publication Date: 1/27/2018 12:08:00 AM
      ISBN13: 9781498745307, 978-1498745307
      ISBN10: 149874530X

      Description

      Book Synopsis

      Following the success of the first edition, this book is designed to provide practical and timely information for toxicologic pathologists working in pharmaceutical drug discovery and development. The majority of the book (Organ Systems) will provide detailed descriptions of histopathological lesions observed in drug development. In addition, it will provide information to assist the pathologist in making determinations of the origin of lesions as well as its relevance to human risk.

      Toxicologic Pathology: Nonclinical Safety Assessment, Second Edition includes 2 new concept chapters. The first of the new chapters address approaches for the evaluation of unique therapeutic modalities such as cell therapies, gene therapies, and gene expression knockdown therapies. While these still represent new developing therapeutic approaches, there has been significant experience with the therapeutic modalities in the last 5 years. The second new chapter ad

      Trade Review

      "...the editors have achieved a truly remarkable feat in pulling together over 70 of the top toxicologic pathologists, the majority of whom are still practicing in their respective fields.

      "This book has much to recommend it to both the experienced toxicologist and toxicologic pathologist and to beginners in the field of drug development. The accumulated knowledge of the contributing authors, much of which has never been published before, makes this a classic that should be in use for many years to come."

      -John R. Foster, ToxPath Sciences Ltd, Congleton, Cheshire, UK
      Toxicologic Pathology 2019, Vol. 47(7) 902

      Full review available at: https://journals.sagepub.com/doi/pdf/10.1177/0192623319861939


      "...the editors have achieved a truly remarkable feat in pulling together over 70 of the top toxicologic pathologists, the majority of whom are still practicing in their respective fields.

      "This book has much to recommend it to both the experienced toxicologist and toxicologic pathologist and to beginners in the field of drug development. The accumulated knowledge of the contributing authors, much of which has never been published before, makes this a classic that should be in use for many years to come."

      -John R. Foster, ToxPath Sciences Ltd, Congleton, Cheshire, UK
      Toxicologic Pathology 2019, Vol. 47(7) 902

      Full review available at: https://journals.sagepub.com/doi/pdf/10.1177/0192623319861939



      Table of Contents

      Preface

      Acknowledgments

      Editors

      Contributors

      Section I Concepts in Drug Development

      Chapter 1 Overview of Drug Development

      James A. Popp and Jeffery A. Engelhardt

      Chapter 2 Nonclinical Safety Evaluation of Drugs

      Thomas M. Monticello and Jeanine L. Bussiere

      Chapter 3 Nonclinical Safety Evaluation of Advanced Therapies

      Timothy K. MacLachlan, Kendall S. Frazier, and Mercedes Serabian

      Chapter 4 Nonclinical Safety Evaluation of Medical Devices

      Kathleen A. Funk, Victoria A. Hampshire, and JoAnn C. L. Schuh

      Chapter 5 Pathology and the Pathologist in Pharmaceutical Research and Development

      Page R. Bouchard, Christopher J. Clarke, and Dominique Brees

      Chapter 6 Routine and Special Techniques in Toxicologic Pathology

      Daniel J. Patrick, Matthew L. Renninger, and Peter C. Mann

      Chapter 7 Principles of Clinical Pathology

      Niraj K. Tripathi and Jacqueline M. Tarrant

      Chapter 8 Toxicokinetics and Drug Disposition

      David D. Christ

      Chapter 9 Toxicogenomics in Toxicologic Pathology

      Arun R. Pandiri, David E. Malarkey, and Mark J. Hoenerhoff

      Chapter 10 Spontaneous Lesions in Control Animals Used in Toxicity Studies

      Robert C. Johnson, Robert H. Spaet, Gitte Jeppesen, Ursula Junker, and Robert Stull

      Section II Organ Systems

      Chapter 11 Gastrointestinal Tract

      Judit E. Markovits, Graham R. Betton, Donald N. McMartin, and Theresa Boulineau

      Chapter 12 Liver, Gallbladder, and Exocrine Pancreas

      Russell C. Cattley, James A. Popp, and Steven L. Vonderfecht

      Chapter 13 Respiratory System

      Tom P. McKevitt and David J. Lewis

      Chapter 14 Urinary System

      Kendall S. Frazier and John Curtis Seely

      Chapter 15 Hematopoietic System

      Kristin Henson, Tanasa Osborne, and Gregory S. Travlos

      Chapter 16 The Lymphoid System

      Patrick J. Haley

      Chapter 17 Bone, Muscle, and Tooth

      John L. Vahle, Joel R. Leininger, Philip H. Long, D. Greg Hall, and Heinrich Ernst

      Chapter 18 The Cardiovascular System

      Calvert Louden, David Brott, Chidozie J. Amuzie, Bindu Bennet, and Ronnie Chamanza

      Chapter 19 Endocrine Glands

      Richard A. Peterson, Sundeep Chandra, and Mark J. Hoenerhoff

      Chapter 20 Reproductive System and Mammary Gland

      Justin D. Vidal, Charles E. Wood, Karyn Colman, Katharine M. Whitney, and Dianne M. Creasy

      Chapter 21 Skin

      Zbigniew W. Wojcinski, Lydia Andrews-Jones, Daher Ibrahim Aibo, Rie Kikkawa, and Robert Dunstan

      Chapter 22 Nervous System

      Mark T. Butt, Alys Bradley, and Robert Sills

      Chapter 23 Special Senses: Eye and Ear

      Kenneth A. Schafer, Oliver C. Turner, and Richard A. Altschuler

      Index

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account